http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108524495-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108524495-B |
| titleOfInvention | Purposes of the orlistat in the drug of preparation treatment constipation |
| abstract | The invention belongs to field of medicaments, and in particular to purposes of the orlistat in preparation treatment constipation drug.The drug includes a effective amount of orlistat and a effective amount of konjac mannan oligosaccharide with different molecular weight, drug of the present invention is made of konjac mannan oligosaccharide and orlistat by a certain amount ratio, it is surprised to find, the drug has the function of significantly improving constipation symptom, oil mark caused by taking orlistat, fatty stool adverse reaction can significantly be mitigated simultaneously, achieve significant progress compared with prior art. |
| priorityDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.